Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REBACIN vs interferon alpha-2b vs blank control for clearance of persistent high-risk HPV infection
ChiCTR2100045911Phase 3Completed
- Sponsor
- Anhui Province Maternity and Child Health Hospital
- Start
- Jun 2019
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ribostamycin and interferon alfa-2b in human papillomavirus infection (3 arms), sponsored by Anhui Province Maternity and Child Health Hospital. Primary endpoints: HPV E6/E7 mRNA and HPV-DNA genotyping test. Started Jun 2019; status: completed.
02
Drugs
ribostamycininterferon alfa-2b
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on ChiCTR2100045911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045911.